Generics
Zentiva announces sale from Advent to GTCR
12 September 2025 - Generics pharmaceutical company Zentiva, together with private equity investors Advent and GTCR, on Thursday announced the sale of Zentiva by Advent to GTCR.Since acquiring Zentiva...
Biocon's first US manufacturing facility inaugurated in Cranbury, New Jersey
11 September 2025 - Biocon Limited (BSE:532523) (NSE:BIOCON), an India-based global biopharmaceutical company, announced on Wednesday the inauguration of its first US manufacturing facility in Cranbur...
Amneal's risperidone extended-release injectable suspension approved by US FDA
5 September 2025 - Biopharmaceutical company Amneal Pharmaceuticals Inc announced on Thursday that the US Food and Drug Administration (FDA) has approved risperidone extended-release injectable suspen...
First FDA acceptance to waive clinical efficacy studies for monoclonal antibody biosimilars
2 September 2025 - Regulatory advisory Pharmaceutical Scientist Inc announced on Monday that Professor Sarfaraz K. Niazi, Adjunct Professor at the University of Illinois at Chicago and founder of mult...
Coya Therapeutics wins FDA clearance to advance COYA 302 into Phase 2 ALS trial
25 August 2025 - Biotechnology company Coya Therapeutics Inc (NASDAQ: COYA) announced on Monday that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) applica...
Viatris' generic iron sucrose injection gains US FDA approval
12 August 2025 - Viatris Inc (Nasdaq:VTRS), a US-based global healthcare company, announced on Monday that the US Food and Drug Administration (FDA) has approved Iron Sucrose Injection, USP, an intrav...